Ultrasound-guided injections for the retrotrochanteric region: A cadaveric investigation


Mezian K., Ricci V., Chang K., Mittal N., Vacek J., Nanka O., ...More

PM&R, 2025 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Publication Date: 2025
  • Doi Number: 10.1002/pmrj.13381
  • Journal Name: PM&R
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
  • Hacettepe University Affiliated: Yes

Abstract

BackgroundInjections for the piriformis and triceps coxae tendons/bursae have not been described and validated.ObjectiveTo investigate the deep retrotrochanteric anatomy and validate an ultrasound (US)-guided injection technique.MethodsFifteen sides of the pelvic half/lower limb of formalin-fixed cadaveric specimens were dissected to investigate the deep retrotrochanteric region. An US-guided superficial/peritendinous green latex dye injection was performed on both sides of a single full body cadaver. Next, seven sides of another four full body cadavers were injected using a deep/intrabursal technique. The cadavers were dissected to observe the dye's location.ResultsIn the anatomical part of the study, we observed a consistent fusion of the piriformis tendon (PT) with the triceps coxae tendon (TCT) (15/15), and with the gluteus medius tendon in 93% (14/15). A bursa of piriformis was identified in 80% (12/15) of the cases, and a subtendinous bursa of obturator internus was found in 73% (11/15). A fat pad overlying the PT-TCT was present in 93% (14/15) of the cases. Regarding the US-guided injections, success rate for superficial/peritendinous injection was 0% (0/2), with the latex dye being identified in the fat pad covering the PT-TCT in both cases. For the deep/intrabursal injection, the success rate was 86% (6/7).ConclusionsThe results indicated a satisfactory success rate for the deep/intrabursal injection of PT-TCT in retrotrochanteric pain syndrome. This technique holds promise for the treatment of bursa and tendon pathologies in relevant patients.